Phenotypic differentiation does not affect tumorigenicity of primary human colon cancer initiating cells

Cancer Letters

Volumn 371, Issue 2, 2016, Pages 326-333

  Dubash, Taronish D ^a   Hoffmann, Christopher M ^a   Oppel, Felix ^a   Giessler, Klara M ^a   Weber, Sarah ^a   Dieter, Sebastian M ^a   Hüllein, Jennifer ^a   Zenz, Thorsten ^a   Herbst, Friederike ^a   Scholl, Claudia ^a   Weichert, Wilko ^b,c,d   Werft, Wiebke ^a   Benner, Axel ^a   Schmidt, Manfred ^a,d   Schneider, Martin ^b   Glimm, Hanno ^a,d   Ball, Claudia R ^a,d  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d German Consortium for Translational Cancer Research (DKTK)   (Germany)

Author keywords

Colon cancer; Phenotypic differentiation; Tumor initiating cells

Indexed keywords

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; CELL ADHESION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MIDDLE AGED; MOUSE; NONHUMAN; PHENOTYPIC PLASTICITY; PRIMARY TUMOR; PRIORITY JOURNAL; TUMOR CELL; TUMOR DIFFERENTIATION; TUMOR INITIATING CELL; TUMOR SPHEROID; VERY ELDERLY; XENOTRANSPLANTATION; ANIMAL; CANCER STEM CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; COLORECTAL TUMOR; GENETICS; METABOLISM; MULTICELLULAR SPHEROID; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHENOTYPE; PRIMARY CELL CULTURE; TIME FACTOR; TRANSGENIC MOUSE; TUMOR CELL CULTURE; TUMOR VOLUME; XENOGRAFT;

TUMOR MARKER;

ANIMALS; BIOMARKERS, TUMOR; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; COLORECTAL NEOPLASMS; HETEROGRAFTS; HUMANS; MICE, INBRED NOD; MICE, TRANSGENIC; NEOPLASTIC STEM CELLS; PHENOTYPE; PRIMARY CELL CULTURE; SPHEROIDS, CELLULAR; TIME FACTORS; TUMOR BURDEN; TUMOR CELLS, CULTURED;

EID: 84961999756     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.11.037     Document Type: Article

References (32)

1. Herszenyi L., Tulassay Z. Epidemiology of gastrointestinal and liver tumors. Eur. Rev. Med. Pharmacol. Sci 2010, 14:249-258.
2. Cancer Genome Atlas Network Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012, 487:330-337.
3. van de Wetering M., Francies H.E., Francis J.M., Bounova G., Iorio F., Pronk A., et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 2015, 161:933-945.
4. Vogelstein B., Papadopoulos N., Velculescu V.E., Zhou S., Diaz L.A., Kinzler K.W. Cancer genome landscapes. Science 2013, 339:1546-1558.
5. Wood L.D., Parsons D.W., Jones S., Lin J., Sjoblom T., Leary R.J., et al. The genomic landscapes of human breast and colorectal cancers. Science 2007, 318:1108-1113.
6. Dieter S.M., Ball C.R., Hoffmann C.M., Nowrouzi A., Herbst F., Zavidij O., et al. Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. Cell Stem Cell 2011, 9:357-365.
7. Kreso A., O'Brien C.A., van Galen P., Gan O.I., Notta F., Brown A.M., et al. Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer. Science 2013, 339:543-548.
8. Schepers A.G., Snippert H.J., Stange D.E., van den Born M., van Es J.H., van de Wetering M., et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 2012, 337:730-735.
9. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:3983-3988.
10. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med 1997, 3:730-737.
11. Collins A.T., Berry P.A., Hyde C., Stower M.J., Maitland N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005, 65:10946-10951.
12. Curley M.D., Garrett L.A., Schorge J.O., Foster R., Rueda B.R. Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer. Front. Biosci 2011, 16:368-392.
13. Hermann P.C., Huber S.L., Herrler T., Aicher A., Ellwart J.W., Guba M., et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1:313-323.
14. O'Brien C.A., Pollett A., Gallinger S., Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-110.
15. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115.
16. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003, 63:5821-5828.
17. Fanali C., Lucchetti D., Farina M., Corbi M., Cufino V., Cittadini A., et al. Cancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectives. World J. Gastroenterol 2014, 20:923-942.
18. Haraguchi N., Inoue H., Tanaka F., Mimori K., Utsunomiya T., Sasaki A., et al. Cancer stem cells in human gastrointestinal cancers. Hum. Cell 2006, 19:24-29.
19. Kreso A., van Galen P., Pedley N.M., Lima-Fernandes E., Frelin C., Davis T., et al. Self-renewal as a therapeutic target in human colorectal cancer. Nat. Med 2014, 20:29-36.
20. Arens A., Appelt J.U., Bartholomae C.C., Gabriel R., Paruzynski A., Gustafson D., et al. Bioinformatic clonality analysis of next-generation sequencing-derived viral vector integration sites. Hum. Gene Ther. Methods 2012, 23:111-118.
21. Paruzynski A., Arens A., Gabriel R., Bartholomae C.C., Scholz S., Wang W., et al. Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing. Nat. Protoc 2010, 5:1379-1395.
22. Hummel M., Meister R., Mansmann U. GlobalANCOVA: exploration and assessment of gene group effects. Bioinformatics 2008, 24:78-85.
23. Wu D., Smyth G.K. Camera: a competitive gene set test accounting for inter-gene correlation. Nucleic Acids Res 2012, 40:e133.
24. Clarke M.F., Dick J.E., Dirks P.B., Eaves C.J., Jamieson C.H., Jones D.L., et al. Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006, 66:9339-9344.
25. Schmidt M., Schwarzwaelder K., Bartholomae C., Zaoui K., Ball C., Pilz I., et al. High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR). Nat. Methods 2007, 4:1051-1057.
26. Han M.E., Baek S.J., Kim S.Y., Kang C.D., Oh S.O. ATOH1 can regulate the tumorigenicity of gastric cancer cells by inducing the differentiation of cancer stem cells. PLoS ONE 2015, 10:e0126085.
27. Kemper K., Sprick M.R., de Bree M., Scopelliti A., Vermeulen L., Hoek M., et al. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Res 2010, 70:719-729.
28. Chaffer C.L., Marjanovic N.D., Lee T., Bell G., Kleer C.G., Reinhardt F., et al. Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 2013, 154:61-74.
29. Morel A.P., Lievre M., Thomas C., Hinkal G., Ansieau S., Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 2008, 3:e2888.
30. Francescangeli F., Contavalli P., De Angelis M.L., Baiocchi M., Gambara G., Pagliuca A., et al. Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer. Cell Death Differ 2015, 22:1700-1713.
31. Taub M., Wang Y., Szczesny T.M., Kleinman H.K. Epidermal growth factor or transforming growth factor alpha is required for kidney tubulogenesis in matrigel cultures in serum-free medium. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:4002-4006.
32. Pollard S.M., Yoshikawa K., Clarke I.D., Danovi D., Stricker S., Russell R., et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 2009, 4:568-580.